NCT06399419 2024-05-30CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerOsel, Inc.Phase 1 Recruiting28 enrolled
NCT03545971 2023-02-28A Study of IBI310 for the Treatment of Patients With Advanced Solid Tumors.Innovent Biologics (Suzhou) Co. Ltd.Phase 1 Completed53 enrolled